Acasti pharma merger investigation: halper sadeh llp announces investigation into whether the merger of acasti pharma inc. is fair to shareholders; investors are encouraged to contact the firm – acst

New york--(business wire)--halper sadeh llp, a global investor rights law firm, is investigating whether the merger of acasti pharma inc. (nasdaq: acst) and grace therapeutics inc. is fair to acasti shareholders. under the merger, grace stockholders will receive newly issued acasti common shares. upon closing, acasti securityholders are expected to own approximately 55% of the combined company's common shares on a pro forma basis, subject to certain adjustments. halper sadeh encourages acasti s
ACST Ratings Summary
ACST Quant Ranking